CATALOGO DEI PRODOTTI DELLA RICERCA

PERBELLINI, Omar
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.312
EU - Europa 5.949
AS - Asia 3.843
SA - Sud America 420
AF - Africa 77
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 5
Totale 16.624
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.172
RU - Federazione Russa 2.024
GB - Regno Unito 1.392
SG - Singapore 1.376
CN - Cina 1.353
DE - Germania 595
IT - Italia 413
SE - Svezia 402
BR - Brasile 319
VN - Vietnam 318
FI - Finlandia 293
HK - Hong Kong 288
FR - Francia 276
IE - Irlanda 245
KR - Corea 115
CA - Canada 82
IN - India 76
UA - Ucraina 63
BD - Bangladesh 62
NL - Olanda 53
TR - Turchia 47
JP - Giappone 45
BE - Belgio 40
MX - Messico 37
PL - Polonia 31
AR - Argentina 30
ES - Italia 28
ID - Indonesia 26
ZA - Sudafrica 24
NG - Nigeria 19
EC - Ecuador 16
UZ - Uzbekistan 16
AU - Australia 15
CL - Cile 14
CO - Colombia 14
IQ - Iraq 14
IR - Iran 14
PK - Pakistan 14
AT - Austria 13
RO - Romania 12
LT - Lituania 11
NP - Nepal 10
VE - Venezuela 10
TW - Taiwan 8
PE - Perù 7
HU - Ungheria 6
KE - Kenya 6
KZ - Kazakistan 6
MA - Marocco 6
AE - Emirati Arabi Uniti 5
CH - Svizzera 5
CR - Costa Rica 5
DK - Danimarca 5
GR - Grecia 5
IL - Israele 5
LV - Lettonia 5
OM - Oman 5
PH - Filippine 5
PY - Paraguay 5
SI - Slovenia 5
AL - Albania 4
BG - Bulgaria 4
CZ - Repubblica Ceca 4
HR - Croazia 4
JO - Giordania 4
PA - Panama 4
TH - Thailandia 4
AM - Armenia 3
BO - Bolivia 3
CY - Cipro 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
EU - Europa 3
MY - Malesia 3
NZ - Nuova Zelanda 3
SA - Arabia Saudita 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AZ - Azerbaigian 2
BH - Bahrain 2
BJ - Benin 2
ET - Etiopia 2
GE - Georgia 2
HN - Honduras 2
JM - Giamaica 2
LU - Lussemburgo 2
NO - Norvegia 2
PS - Palestinian Territory 2
PT - Portogallo 2
RS - Serbia 2
RW - Ruanda 2
TG - Togo 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AO - Angola 1
BB - Barbados 1
BF - Burkina Faso 1
CD - Congo 1
CG - Congo 1
EG - Egitto 1
Totale 16.608
Salva come PNG Salva come JPEG
Città #
Southend 1.149
Ashburn 737
Singapore 734
Moscow 713
Chandler 584
Dallas 524
San Jose 521
Jacksonville 456
Woodbridge 421
Ann Arbor 397
Beijing 288
Hong Kong 279
Dublin 245
Munich 202
New York 187
Verona 159
The Dalles 154
Houston 137
Wilmington 125
Council Bluffs 118
Los Angeles 111
Helsinki 101
Jinan 95
Ho Chi Minh City 92
Lawrence 87
Princeton 87
Nanjing 80
Hanoi 78
Shenyang 65
Tianjin 64
Buffalo 49
Hebei 45
São Paulo 45
Orem 42
Turku 42
Falls Church 40
Tokyo 39
Brussels 38
Columbus 38
Haikou 35
Hangzhou 35
Santa Clara 35
Boardman 33
Ningbo 33
Manchester 32
Montreal 31
Nanchang 31
Zhengzhou 31
Changsha 30
Guangzhou 30
Chennai 28
Seoul 28
Frankfurt am Main 27
Milan 27
Stockholm 27
London 26
Norwalk 24
Warsaw 24
Johannesburg 22
Taiyuan 22
Groningen 21
Redondo Beach 21
Sindelfingen 20
Taizhou 20
Boston 19
Amsterdam 18
Brooklyn 18
Chicago 18
Denver 18
Seattle 18
Dearborn 17
Jiaxing 17
Düsseldorf 16
Nürnberg 16
Abuja 15
Fuzhou 15
San Francisco 15
Toronto 15
Haiphong 14
Paris 14
Tashkent 14
Dong Ket 13
Jakarta 13
Lanzhou 13
Bologna 12
Falkenstein 12
Phoenix 12
Redmond 12
Atlanta 11
Charlotte 11
Da Nang 11
Kent 11
Redwood City 11
Rome 11
Washington 11
Mexico City 10
Mumbai 10
Santiago 10
Augusta 9
Barnet 9
Totale 10.550
Salva come PNG Salva come JPEG
Nome #
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients 459
Epidemiology of mastocytosis in adults based on a multidisciplinary diagnostic approach. 333
DEATH RECEPTOR 3 EXPRESSION AND SERUM LEVEL OF SOLUBLE TL1A CORRELATE WITH INDOLENT, EARLY STAGE B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA 266
Endothelin B Receptor (Etbr) expression by human malignant plasma cells: preliminary evidence for a role of the endothelin axis in multiple myeloma. 262
Association between B-cell receptor responsiveness and disease progression in B-cell chronic lymphocytic leukemia: results from single cell network profiling studies 256
Prognostic value of serum markers of established impact on prognosis in relation with ZAP-70 expression in B-CLL patients 249
Analysis of B-cell receptor signal transduction in B-cell chronic lymphocytic leukemia by phosphospecific flow-cytometry 249
A quantitative study on the growth variability of tumour cell clones in vitro 248
NON-CANONICAL NOTCH SIGNALING IN T-ALL: A PHOSPHO-FLOW CYTOMETRY STUDY 240
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients. 239
EXPRESSION AND FUNCTIONAL ACTIVITY OF DEATH RECEPTOR 3 IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA 237
Expression and function of the TL1A/DR3 axis in chronic lymphocytic leukemia 233
BCR-signaling profiles associated with prognosis and progression in B-CLL 232
CXCL12-MEDIATED NF-KAPPAB AND C-JUN ACTIVATION REGULATES INTERLEUKIN 8 PRODUCTION IN HUMAN T-LYMPHOBLASTIC LEUKEMIA 229
Clonal mast cell disorders limited to bone marrow: not a negligible disease. 226
BCR-signaling profiles associated with prognosis and progression in B-CLL 220
Double productive immunoglobulin sequence rearrangements in patients with chronic lymphocytic leukemia 220
Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways 219
CXCL8 and interleukin-6 in B-cell chronic lymphocytic leukemia are up-reuglated through the activity of CXCL12 219
Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia 217
SINGLE-CELL PROFILES OF B-CELL RECEPTOR PHOSPHO-PROTEIN NETWORKS ASSOCIATED WITH PROGNOSIS AND PROGRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA 216
CXCL8/interleukin 8 in B-cell chronic lymphocytic leukemia is up-regulated through the activity of the CXCL12/CXCR4 axis 215
Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels 211
Autoimmune complications are frequent in splenic and nodal marginal zone lymphomas 211
Rapid reconstitution of functionally active 6-sulfoLacNAc(+) dendritic cells (slanDCs) of donor origin following allogeneic haematopoietic stem cell transplant 211
Characterization of the cross-talk between human neutrophils and a subset of pro-inflammatory dendritic cells 210
A simple score predicts clonal mast cell disorders in patients with systemic reactions to Hymenoptera venom without skin lesions 210
Allergen specific immunotherapy is safe and effective in patients with systemic mastocytosis and hymenopteria allergy 207
Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels 204
Cross-talks within the innate immune system: the role of neutrophils 203
METHODOLOGICAL APPROACH TO MINIMAL RESIDUAL DISEASE DETECTION BY FLOW CYTOMETRY IN ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA 202
Integrated single cell network profiling data of ERK signaling and mutations of SF3B1 gene refine prognosis in chronic lymphocytic leukemia 201
Clinical significance of LAIR1 (CD305) as assessed by flow cytometry in a prospective series of patients with chronic lymphocytic leukemia 201
Immunomodulation after radiofrequency ablation of locally advanced pancreatic cancer by monitoring the immune response in 10 patients 200
Effects of wheat germ agglutinin on human gastrointestinal epithelium: insights from an experimental model of immune/epithelial cell interaction 199
Human neutrophils interact with both 6-sulfo LacNAc+ DC and NK cells to amplify NK-derived IFN{gamma}: role of CD18, ICAM-1 and ICAM-3 199
Value of flow cytometry in the diagnosis of indolent systemic mastocytosis. 199
Jagged-1, Jagged-2 and DLL-1 are the elements of Notch signaling mainly responsible for the antiapoptotic effect on B-lineage acute lymphoblastic leukemia exerted by bone marrow Mesenchymal Stem Cells 195
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients 193
Somatic D816V KIT mutation in a case of adult-onset familial mastocytosis. 191
A Survey on Clinical and Biological Characteristic and Therapy Management of an Italian Series of 455 Adult Patients with Systemic Mastocytosis on Behalf of Italian Registry of Mastocytosis 191
On the potential involvement of CD11d in co-stimulating the production of interferon-{gamma} by natural killer cells upon interaction with neutrophils via intercellular adhesion molecule-3 189
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients 189
THE COMBINATION OF SERUM THYMIDINE KINASE, B-2-MICROGLOBULIN AND SOLUBLE CD23 AT DIAGNOSIS IS PREDICTIVE FOR PROGRESSION IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA, INDEPENDENTLY FROM ZAP-70 EXPRESSION 187
IN VITRO STUDY OF THE MECHANISMS INVOLVED IN THE BONE MARROW MESENCHY- MAL STROMAL CELL MODULATORY EFFECT ON B CELL FUNCTIONS 187
Low catalase expression confers redox hypersensitivity and identifies an indolent clinical behavior in CLL 187
The impact of sensitive KIT D816V detection on recognition of Indolent Systemic Mastocytosis 182
Human Bone marrow Mesenchymal Stem Cells protect B-cell Acute Lymphoblastic Leukemia from apoptosis in vitro by upregulation of Notch3 and Notch4 on both cell types 181
EXPRESSION AND FUNCTIONAL ACTIVITY OF THE TNFR-SUPERFAMILY MEMBER DEATH RECEPTOR 3 IN CHRONIC LYMPHOCYTIC LEUKEMIA B CELLS ACTIVATED BY THE BCR 181
Improved detection of the C-KIT D816V mutation using allele-specific arms real time PCR assay allows a finer recognition of patients with indolent systemic mastocytosis. 181
Flow cytometry analysis of B-cell receptor phospho-protein networks in chronic lymphocytic leukemia 179
Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia 178
Notch-3 and Notch-4 signaling rescue from apoptosis human B-ALL cells in contact with human bone marrow-derived mesenchymal stromal cells 175
In Vitro Study Of The Mechanisms Involved In The Bone Marrow Mesenchymal Stromal Cell Modulatory Effect On B Cell Function 174
Underdiagnosed systemic mastocytosis: The role of flow cytometry 167
SIGNALING NETWORK IN T-CELL LYMPHOBLASTIC LEUKEMIA: RESULTS FROM A SINGLE-CELL MULTI-PARAMETRIC PHOSPHO-FLOW CYTOMETRY STUDY 167
Isolated bone marrow mastocytosis: an underestimated subvariant of indolent systemic mastocytosis 166
Interleukin 7 requirement for survival of T-cell acute lymphoblastic leukemia and human thymocytes on bone marrow stroma. 166
Adult T-cell acute lymphoblastic leukemia: prognostic impact of myeloid associated antigens. 163
The TNF-Family Cytokine TL1A/Death Receptor 3 System Reduces Metabolic Activity in Chronic Lymphocytic Leukemia B Cells 162
IDENTIFICATION AND CHARACTERIZATION OF CANDIDATE MYELOID DERIVED SUP- PRESSOR CELLS IN THE MONONUCLEAR FRACTION OF PERIPHERAL BLOOD SAMPLES FROM PATIENTS AFFECTED BY NON-HODGKIN LYMPHOMA (NHL), HODGKIN LYMPHOMA (HL), AND MULTIPLE MYELOMA (MM) 162
THE TNF-FAMILY CYTOKINE TL1A/DEATH RECEPTOR 3 FUNCTIONAL AXIS MODULATES B- CELL CHRONIC LYMPHOCYTIC LEUKEMIA PROLIFERATION 160
A serum-free protocol for the ex vivo expansion of Cytokine-Induced Killer cells using gas-permeable static culture flasks 160
Epstein-Barr virus DNA load in chronic lymphocytic leukemia is an independent predictor of clinical course and survival 158
The combination of Serum Thymidine Kinase, Beta-2-Microglobulin and soluble CD23 at diagnosis is predictive for progression in B-cell Chronic Lymphocytic Leukemia, independently from ZAP-70 expression 157
Neutrophil activation and survival are modulated by interaction with NK cells 156
Serum tryptase levels differently change over time in indolent systemic mastocytosis with or without skin lesions. 156
Notch-3 and Notch-4 signaling rescues from apoptosis Human B-lineage Acute Lymphoblastic Leukemia cells in contact with Human Bone marrow-derived Mesenchymal Stromal Cells 155
Up-regulation of CXCL8/interleukin-8 production in response to CXCL12 in chronic lymphocytic leukemia 153
CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis 152
Epithelial-to-mesenchymal transition (EMT) induced by inflammatory priming elicits mesenchymal stromal cell-like immune-modulatory properties in cancer cells 150
Bone marrow stromal cells up-regulate interleukin 8 production in human T-lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-κB and JNK/AP-1 pathways 149
High incidence of autoimmune complications in 82 patients with non-MALT marginal zone lymphomas. 148
ZAP-70 expression is associated with increased risk of autoimmune cytopenias in CLL patients 145
Systemic mastocytosis associated with myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis: Report of three cases 142
Ultra-Deep Sequencing (UDS) Allows More Sensitive Detection of the D816V and Other Kit Gene Mutations in Systemic Mastocytosis 134
Multi-parametric phospho-flow cytometry in T-call Acute Lymphoblastic Leukemia 129
Flow cytometric study of potential target antigens (CD19, CD20, CD22, CD33) for antibody-based immunotherapy in acute lymphoblastic leukemia: analysis of 552 cases 128
EPSTEIN-BARR VIRUS DNA LOAD IN CHRONIC LYMPHOCYTIC LEUKEMIA IS AN INDEPENDENT PREDICTOR OF CLINICAL COURSE AND SURVIVAL 128
Systemic Reactions After Hymenoptera Sting And Raised Serum Tryptase Strongly Suggest Clonal Mast Cells Disorders 125
Outcome prediction by immunophenotypic minimal residual disease detection in adult T-cell acute lymphoblastic leukaemia 123
Evans syndrome secondary to chronic lymphocytic leukaemia: presentation, treatment, and outcome 121
Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia 115
Rituximab, bendamustine and cytarabine (R-BAC) in patients with relapsed-refractory aggressive B-cell lymphoma 113
Flow-cytometric detection of minimal residual disease in adult acute lymphoblastic leukemia 108
On the co-purification of 6-sulfo LacNAc(+) dendritic cells (slanDC) with NK cells enriched from human blood. 107
Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells 101
Primary role of multiparametric flow cytometry in the diagnostic work-up of indolent clonal mast cell disorders 96
Prognostic relevance of oxidative stress measurement in chronic lymphocytic leukaemia 74
null 70
null 55
Direct-Acting Antiviral Agents in Hepatitis C-Associated Indolent Lymphomas 1
Totale 16.714
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.785
article - articoli 25.401
book - libri 0
conference - conferenze 24.384
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 99.570
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202136 0 0 0 0 0 0 0 0 0 0 0 36
2021/2022872 86 257 5 83 68 33 20 48 40 23 60 149
2022/20231.667 103 192 134 320 135 403 17 99 206 13 33 12
2023/2024938 51 72 55 76 102 209 60 66 7 47 126 67
2024/20252.148 95 149 85 342 64 95 146 100 359 127 208 378
2025/20266.762 441 385 488 1.151 1.691 455 575 314 550 428 134 150
Totale 16.714